April 5, 2021
“Veritone, Inc. (VERI)… All in all, with a share price of $24.53 and a consensus average price target of $38.75, VERI shares offer investors a chance for 58% share growth this year. The analyst consensus rating, a Moderate Buy, is based… Continue Reading…
March 26, 2021
“BorgWarner, Inc. (BWA)… Brinkman is not an outlier in his bullish stance, but there is some division on Wall Street regarding BWA. The analyst consensus view is a Moderate Buy, based on 14 recent reviews breaking down to 8 Buys, 5… Continue Reading…
March 17, 2021
“It has long been said that when America, still the world’s largest economy, catches a cold, the rest of the world economy catches pneumonia. With America now engaged in a budget and monetary policy stimulus experiment of epic proportions, the rest of the… Continue Reading…
March 9, 2021
“After plunging into recession for the first time in nearly a quarter of a century, India’s economyshouldcome roaring back to life in 2021.India’s gross domestic product is projected to expand by 12.6% during the country’s fiscal year starting in April, according toa… Continue Reading…
February 26, 2021
“China stands a good chance of doubling the size of its economy by 2035 — and surpassing the U.S. as the world’s largest economy along the way, said an economist from the Bank of America. As China seeks to become an advanced… Continue Reading…
February 17, 2021
“Yields on some Treasury bills—short-term securities that mature in a year or less—could temporarily turn negative because of a coming supply crunch, experts say. While they won’t be auctioned by the U.S. at rates below zero, as auction rules prevent that, bills… Continue Reading…
February 9, 2021
“Guild Holdings (GHLD)… …4 Buys and 1 Hold assigned in the last three months add up to a Strong Buy analyst consensus. The stock is selling for $16.21, and its $19.30 average price target implies a 19% one-year upside… PDC Energy (PDCE)…… Continue Reading…
January 21, 2021
“AzurRx BioPharma (AZRX)… Overall, the analyst consensus on AZRX shares is a Strong Buy; the stock has 4 recent reviews, including 3 Buys and a single Hold. In addition, the $4 average price target brings the upside potential to 304%…… Continue Reading…
January 13, 2021
“AcelRx Pharmaceuticals (ACRX)… Turning now to the rest of the Street, 3 Buys and no Holds or Sells have been published in the last three months. Therefore, ACRX has a Strong Buy consensus rating. Based on the $7 average price target,… Continue Reading…
January 8, 2021
“…“We’re still working through the models because we don’t have visibility around the timing of [legislation] but we would anticipate either the back half of ’21 or the first half of ’22,” Azer said. “But what we have asserted is… Continue Reading…
Recent Comments